431 related articles for article (PubMed ID: 37887011)
1. Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies.
Dey AK; Banarjee R; Boroumand M; Rutherford DV; Strassheim Q; Nyunt T; Olinger B; Basisty N
Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887011
[TBL] [Abstract][Full Text] [Related]
2. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
3. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets.
Rossi M; Abdelmohsen K
Cells; 2021 Jul; 10(7):. PubMed ID: 34359910
[TBL] [Abstract][Full Text] [Related]
4. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.
Basisty N; Kale A; Patel S; Campisi J; Schilling B
Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074
[TBL] [Abstract][Full Text] [Related]
5. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
6. Exploring the fuzzy border between senolytics and senomorphics with chemoinformatics and systems pharmacology.
Olascoaga-Del Angel KS; Gutierrez H; Königsberg M; Pérez-Villanueva J; López-Diazguerrero NE
Biogerontology; 2022 Aug; 23(4):453-471. PubMed ID: 35781578
[TBL] [Abstract][Full Text] [Related]
7. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
[TBL] [Abstract][Full Text] [Related]
8. Translation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and Models.
Inci N; Kamali D; Akyildiz EO; Tahir Turanli E; Bozaykut P
Front Aging; 2022; 3():828058. PubMed ID: 35821852
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted senotherapeutic interventions.
Atayik MC; Çakatay U
Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
[TBL] [Abstract][Full Text] [Related]
10. Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy.
Liu H; Xu Q; Wufuer H; Li Z; Sun R; Jiang Z; Dou X; Fu Q; Campisi J; Sun Y
Aging Cell; 2024 Jan; 23(1):e13921. PubMed ID: 37475161
[TBL] [Abstract][Full Text] [Related]
11. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle aging, cellular senescence, and senotherapeutics: Current knowledge and future directions.
Englund DA; Zhang X; Aversa Z; LeBrasseur NK
Mech Ageing Dev; 2021 Dec; 200():111595. PubMed ID: 34742751
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics.
Oguma Y; Alessio N; Aprile D; Dezawa M; Peluso G; Di Bernardo G; Galderisi U
Cell Commun Signal; 2023 Sep; 21(1):262. PubMed ID: 37770897
[TBL] [Abstract][Full Text] [Related]
14. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
[TBL] [Abstract][Full Text] [Related]
15. The Potential Role and Therapeutic Relevance of Cellular Senescence in Skeletal Pathophysiology.
Li B; Lyu P; Tang J; Li J; Ouchi T; Fan Y; Zhao Z; Li L
J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38306619
[TBL] [Abstract][Full Text] [Related]
16. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
17. Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics.
Riessland M; Orr ME
J Prev Alzheimers Dis; 2023; 10(4):633-646. PubMed ID: 37874084
[TBL] [Abstract][Full Text] [Related]
18. Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.
Suda M; Paul KH; Minamino T; Miller JD; Lerman A; Ellison-Hughes GM; Tchkonia T; Kirkland JL
Cells; 2023 May; 12(9):. PubMed ID: 37174697
[TBL] [Abstract][Full Text] [Related]
19. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
Murakami T; Inagaki N; Kondoh H
Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
[TBL] [Abstract][Full Text] [Related]
20. Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases.
Matsubayashi S; Ito S; Araya J; Kuwano K
Front Endocrinol (Lausanne); 2023; 14():1079626. PubMed ID: 37077349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
